Psychosis Associated With Alzheimer's Disease trials recruiting in New York

Recruiting in New York

Cities with sites

Cities in New York

Manhasset 2New York 2Stony Brook 2Woodmere 2New Hyde Park 1Port Jefferson Station 1Staten Island 1Syracuse 1

A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-1)
NCT05511363 · Phase: Phase 3 · Ages: 55 Years to 90 Years · Sex: All (male and female) · New York: Manhasset, New York, Staten Island, Stony Brook
A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-2)
NCT06126224 · Phase: Phase 3 · Ages: 55 Years to 90 Years · Sex: All (male and female) · New York: New Hyde Park, Port Jefferson Station
Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3)
NCT05980949 · Phase: Phase 3 · Ages: 55 Years to 90 Years · Sex: All (male and female) · New York: Manhasset, New York, Stony Brook, Syracuse